The Fox News Rundown The President Takes On Big Pharma
Oct 1, 2025
Chris Klomp, Medicare director at the Centers for Medicare and Medicaid Services, discusses a new deal to lower Medicaid drug prices and the implications of tariffs on domestic pharmaceutical manufacturing. He also emphasizes the importance of price transparency for consumers. Retired Lieutenant Colonel Robert McGinnis shares insights on military readiness, advocating for tougher training standards amidst rising global threats and the restoration of a disciplined 'warrior ethos.' The conversation is both timely and critical in addressing healthcare and military standards.
AI Snips
Chapters
Books
Transcript
Episode notes
Tariffs Plus MFN To Lower Drug Prices
- The administration tied tariffs and price guarantees to force drugmakers to match lowest wealthy-country prices for Medicaid and new drugs.
- This aims to lower U.S. prices while preserving access and innovation by negotiating across manufacturers and sovereigns.
Shop Prices And Pressure Insurers
- Use trumprx.gov to compare reference prices and empower price-shopping at the pharmacy counter.
- If you find a lower price, bring it to your insurer or PBM to trigger competition and lower costs.
Price Cuts Tied To Reshoring
- The Pfizer deal combined price cuts with a commitment to onshore production to avoid tariffs and bolster supply chains.
- The policy links affordability goals with national security and domestic manufacturing incentives.
